Bioconvergence is the cornerstone of the Einstein Biotech Innovation Program!
About us
Einstein Biotech Innovation Program is an initiative from Hospital Israelita Albert Einstein, one of the leading healthcare institutions in Latin America and the 34th best hospital in the world.
In 2021, Einstein was awarded as the 6th most innovative company in Brazil and the leader among healthcare organizations. Its Innovation Board was founded in 2014 and since then it has developed or worked in collaboration with more than 200 national and international startups, incluinding several of Brazilian biotechs.
How our program works
Innovation residency for PhDs to support turning scientific projects into interventions that can globally improve individuals’ health.
Support for national and international Biotech startups with different technological maturities for both product and business development.
These are the structures that enable the entire product development cycle in the healthcare area.
The program will be carried out through Eretz.bio Biotech, based in Einstein’s new Teaching and Research Center, in the Morumbi complex.
Complete infrastructure for carrying out all phases of product development and validation: proof of concept, preclinical and clinical studies.
Be a partner of this movement
and take biotech innovation from within your company to the
next level.
Be a partner of this movement
and take biotech innovation from within your company to the
next level.
The program has a network of many international partners for technology exchange, mentoring, investments and business acceleration.
Let’s build together
the future of medicine
Privacy Policies | FAQ
Copyright © 2022 Copyright © 2021 Hospital Israelita Albert Einstein. all rights reserved
